Status:
RECRUITING
Evaluation of the Prognostic Impact of a Neuro-vascular Examination Associated with Cerebral MRI in the Acute Phase of Infectious Endocarditis
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Endocarditis
Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Infectious endocarditis (IE) is a serious condition with an annual incidence of 3 to 10 per 100,000 people. Brain infarctions complicate approximately 20-40% of endocarditis. Brain MRI can detect the...
Eligibility Criteria
Inclusion
- Adult patients
- Certain infectious endocarditis according to Dukes Criteria
- Signed informed consent
Exclusion
- Hospital admission due to neurovascular emergency
- MRI contraindications
- Pregnant or women of childbearing age who were not using contraception (oral diagnosis),
- Patient without health coverage,
- Patient under legal protection.
Key Trial Info
Start Date :
April 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05378126
Start Date
April 6 2023
End Date
July 1 2026
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stroke Unit, Pierre Wertheimer hospital, GHE Hospices Civils de Lyon
Bron, France, 69500